Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease

BACKGROUND: Angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor antagonists (AIIRA) are considered to be equally effective for patients with diabetic kidney disease (DKD), but renal and not mortality outcomes have usually been considered. OBJECTIVES: To evaluate the benefits...

Full description

Saved in:
Bibliographic Details
Published in:Cochrane Database Syst Rev
Main Authors: Strippoli, Giovanni FM, Bonifati, Carmen, Craig, Maria E, Navaneethan, Sankar D, Craig, Jonathan C
Format: Artigo
Language:Inglês
Published: John Wiley & Sons, Ltd 2006
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6956646/
https://ncbi.nlm.nih.gov/pubmed/17054288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006257
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items